12th Annual Goodwin Directors Forum
As President and CEO of 92nd Street Y, Mr. Timms creates programs and movements that foster learning, civic responsibility, culture and innovation, both in New York City and around the world. Under his leadership, the 144 year-old institution was named to Fast Company’s “Most Innovative Companies” list. He is the founder of #GivingTuesday, a global philanthropic movement that engages people in close to 100 countries and has generated hundreds of millions of dollars for good causes. Mr. Timms’ work has been profiled in publications like the Harvard Business Review, and his most recent thinking with Jeremy Heimans on “new power” was featured as the Big Idea in HBR and by CNN as one of the ten top ideas to change the world in 2015. Mr. Timms is a Visiting Fellow at Stanford PACS Center on Philanthropy and Civil Society and a member of the World Economic Forum’s Network of Global Agenda Councils. In addition to being listed on The Nonprofit Times Power & Influence Top 50 for the past three years, Mr. Timms was named The Nonprofit Times Influencer of the Year in 2014.
Jeremy Heimans is co-founder and CEO of Purpose, a home for building 21st century movements and crowd-based social and economic models to tackle the world’s biggest problems. In 2005, he co-founded GetUp, an Australian political organization and internationally recognized social movement phenomenon that today has more members than all of Australia’s political parties combined. In 2007, Jeremy was a co-founder of Avaaz, the world’s largest online citizens’ movement, now with more than 43 million members. In 2011, Jeremy received the Ford Foundation’s 75th Anniversary Visionary Award for his work as a movement pioneer and the World Economic Forum named him a Young Global Leader. He also serves as Chair of the Forum’s Global Agenda Council on Civic Participation. In 2012, Fast Company named him one of the Most Creative People in Business. The World e-Government Forum has named him as one of the top ten people who is changing the world of politics and the internet, and The Guardian named him one of the ten most influential voices on sustainability in the US.
Mr. Connors is a founding partner and chairman emeritus of Hill, Holliday, Connors, Cosmopulos, Inc., a full-service marketing communications company. Under his leadership, Hill, Holliday evolved from a one-room shop, founded in 1968, to one of the top 20 advertising firms in the United States. Early in his career, Mr. Connors became interested and active in the philanthropic life of the city of Boston, serving on boards and leading civic campaigns. In fact, throughout Greater Boston, Mr. Connors is known for these efforts as well as for his business acumen. Boston Magazine named him one of the most powerful people in Boston, and he’s been a major force behind initiatives such as The Campaign for Catholic Schools, and The Edward M. Kennedy Institute.
As an articulate advocate for Boston’s world-class hospitals, Jack served as Chairman of the Board of Directors of Partners HealthCare System for 16 years and became Chairman Emeritus in July 2012. He has served on the Boston College Board of Trustees for over 30 years and was Chair of that board for two terms. He is a member of the Board of Directors of Partners-In-Health, the HomeBase Program, Beyond Conflict, the Board of Fellows at Harvard Medical School, and Board of Dean’s Advisors for the Harvard T.H. Chan School of Public Health. The charity that is perhaps closest to his heart is Camp Harbor View, a summer camp in Boston Harbor for inner city youth that he was instrumental in establishing.
Ms. Klee is the Vice President of GE’s Boston Development and Operations, and the global Environment, Health & Safety group. She also serves as President of the GE Foundation. Before coming to GE, Ms. Klee was a partner and co-chair of the Environmental and Natural Resources Group of Crowell & Moring LLP, based in Washington, DC. She spent over a decade in senior positions in the federal government, including as General Counsel of the U.S. Environmental Protection Agency, Counselor and Special Assistant to the Secretary of the U.S. Department of the Interior, and Chief Counsel to the Senate Committee on Environment and Public Works.
Ms. Klee has served on the Board of Trustees of the National Park Foundation, and is currently on the Boards of WGBH in Boston, Boston Harbor Now, the Green Ribbon Commission, the Center for Climate and Energy Strategies, the Environmental Law Institute, Yale Center for Business and Environment, and University of Pennsylvania Law School Board of Overseers.
Mr. Perez is the executive chairman of Akili Interactive, a digital medicine company, and the former CEO of Cubist Pharmaceuticals. Mr. Perez is also the founder and managing partner of Vineyard Sound Advisors, LLC and founder and chairman of Life Science Cares, a collective effort of the life science industry to eliminate the impact of poverty in the greater Boston area.
Prior to joining Cubist Pharmaceuticals, Mr. Perez served as vice president of Biogen's CNS business unit, where he was responsible for leading the U.S. neurology franchise. Mr. Perez currently serves as a member of the board of directors of AMAG Pharmaceuticals, Zafgen, Spark Therapeutics and Unum Therapeutics. He is also a member of the Board of Trustees at The Dana Farber Cancer Institute.
Ms. Salwasser joined the Red Sox Foundation as the Executive Director in January of 2018. She brings extensive experience in philanthropy and both professional and semi-professional sports. After four years working as Community Relations Director for the Boston Celtics, Ms. Salwasser went on to lead Scholar Athletes as its Executive Director, a program that supports public high school athletes with both their athletic and academic achievements. Earlier in her career, Ms. Salwasser was a professional soccer player for the Boston Breakers and served as Executive Director of the Charlestown Lacrosse and Learning Center.
Mr. von Rickenbach took PAREXEL from its pioneering beginnings as one of the first clinical research organizations in the early 1980s to its place as one of the top three public biopharmaceutical services providers. He led PAREXEL through its IPO, multiple public offerings, and over 40 mergers and acquisitions during the Company’s 35-year history. Foreseeing the globalization of clinical research, Mr. von Rickenbach worked to expand PAREXEL’s global footprint to 86 locations in 51 countries.
Mr. von Rickenbach was twice Chairman of the Association of Clinical Research Organizations (ACRO) and was a founding member of the ACRO Board of Directors. Mr. von Rickenbach was named Executive of the Year in North America in the seventh annual International Business Awards, which celebrate managerial excellence worldwide. He serves on the Board of Directors of the NEHI (Network for Excellence in Health Innovation) and on the Health Policy and Management Executive Council of the Harvard School of Public Health. Additionally, he is a Vice Chair of CEOs Against Cancer, sponsored by the American Cancer Society New England Chapter, and serves on the Board of Advisors for the San Francisco-based Life Sciences Foundation, a nonprofit organization dedicated to preserving the history of biotechnology. He also has a long-standing association with the Biomedical Science Careers Program. He joined its Board in 1998 and was appointed Vice President in 2013.
Ms. Birnbach is co-chair of Goodwin’s Public M+A/Corporate Governance practice, and co-chair of Women@Goodwin. She counsels clients and their boards in managing and avoiding litigation risk, and her practice includes securities litigation, including class action defense; SEC, regulatory and internal investigations; M+A-related litigation; stockholder disputes; fiduciary duty claims; and proxy contests. Ms. Birnbach’s securities and shareholder litigation practice is national in scope and involves representing issuers and their directors and officers in securities and corporate governance matters across the country.
Mr. Cable is the chair of Goodwin’s Technology and Life Sciences M&A and Corporate Finance practice, and co-director of Goodwin’s Annual Directors Forum. He represents public and private companies involved in the life sciences and technology sector, as well as private equity and venture sources investing in such companies and investment banks serving such industries. Mr. Cable counsels boards of directors and management teams on corporate governance, mergers and acquisitions, and disclosure and securities law matters. In the course of his career, Mr. Cable has negotiated and executed over 300 M&A transactions. Mr. Cable also serves regularly as counsel to issuers in IPOs, follow-on offerings and convertible debt transactions, and acts regularly as counsel for the underwriters in such transactions.
Mr. Chatterjee is a partner in Goodwin’s Intellectual Property practice. An internationally recognized technology litigator and trial lawyer, Mr. Chatterjee has a proven track record of wins in hard-to-win technology cases. His cases often break new ground in undefined areas of the law. Clients frequently turn to Mr. Chatterjee shortly before trial to handle complex technology cases. He is tireless in his efforts to save companies and product lines, as well as to protect core technologies of his clients. A key strategist on complex litigation spanning multiple venues, Mr. Chatterjee simplifies extremely complex concepts to ensure that the judges and juries understand the key issues in the case. Mr. Chatterjee is committed to the community and engages in significant pro bono work. He has handled globally followed litigation involving civil rights issues for same sex couples, veterans’ rights, immigration rights and countless other issues.
Ms. Fay is a partner in Goodwin’s Labor & Employment practice and a member of the firm’s Executive Committee. She focuses her employment law practice on servicing the firm’s technology, life sciences, private equity/venture capitalist and financial services clients, as a counselor, litigator and employment law compliance expert. Ms. Fay has developed a particular expertise in connection with CEO and other executive transitions, complex workplace investigations, and the development and implementation of proactive human resources strategies, including interactive workplace training. Ms. Fay dedicates much of her practice to investigations related to alleged discrimination/harassment, particularly in the #metoo era, ethics and policy violations, founders’ disputes and whistleblower claims. She is also a subject matter expert on gender pay equity issues.
Ms. Haddad is co-chair of the firm’s Public M+A/Corporate Governance practice, co-chair of Women@Goodwin and co-director of Goodwin’s Annual Directors Forum. Her practice focuses on mergers and acquisitions, corporate governance, securities offerings, securities law compliance for public companies, and general corporate matters. Ms. Haddad has extensive experience in representing buyers and sellers in merger and acquisition transactions involving both public and private companies, especially in the life sciences and technology sectors. Ms. Haddad also advises public companies on a wide variety of corporate and securities matters, including offerings of equity and debt securities.